Danaher | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Abbott USD 1.66B 253M 2025-03
Agilent USD 300M 76M 2025-04
Align Technology USD 131.1M 13.05M 2025-03
Becton, Dickinson and Co. USD 546M 93M 2025-03
Bio Techne USD 47.42M 7.43M 2024-12
Bio-Rad Laboratories USD 23.7M 34.7M 2025-03
Boston Scientific USD 921M 246M 2025-03
Bruker USD 31.8M 32.3M 2025-03
Charles River Laboratories USD 74.67M 242.36M 2025-03
Danaher USD 1.28B 142M 2025-03
Dentsply International USD 63M 572M 2025-03
Edwards Lifesciences USD 394.8M 82.2M 2025-03
ESCO Technologies USD 31.61M 18.45M 2024-12
Exact Sciences USD -96010000 780.34M 2025-03
Fortive USD 233.6M 73.5M 2025-03
Henry Schein USD 175M 20M 2025-03
Hologic USD -7000000 236.8M 2025-03
Illumina USD 131M 44M 2025-03
Intuitive Surgical USD 578.1M 156.8M 2025-03
IQVIA Holdings USD 492M 134M 2025-03
Keysight Technologies USD 207M 11M 2025-04
Laboratory Of America USD 332.4M 115.9M 2025-03
Medtronic USD 1.44B 210M 2025-04
Mettler Toledo International USD 201.94M 112.6M 2025-03
Myriad Genetics USD -29000000 10M 2025-03
Quest Diagnostics USD 346M 15M 2025-03
Quidel USD -100400000 115.4M 2024-12
Repligen USD 6.58M 43.08M 2025-03
Revvity USD 72.23M 46.52M 2025-03
Roper Industries USD 525.8M 1.1M 2025-03
Stryker USD 837M 256M 2025-03
Thermo Fisher Scientific USD 1.72B 300M 2025-03
Waters USD 151.74M 140.52M 2025-03
Zimmer Biomet Holdings USD 389M 109.5M 2024-12



Danaher Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.